Specific Aldosterone Synthase Inhibition: A Potential Improvement Over Mineralocorticoid Receptor Antagonism?

Hypertension. 2017 Jan;69(1):11-12. doi: 10.1161/HYPERTENSIONAHA.116.07939. Epub 2016 Nov 21.

Authors

Markus P Schneider¹, Karl F Hilgers²

Affiliations

¹ From the Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Germany.
² From the Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Germany. Karl.Hilgers@uk-erlangen.de.

PMID: 27872235
DOI: 10.1161/HYPERTENSIONAHA.116.07939

No abstract available

Publication types

Editorial
Comment

MeSH terms

Aldosterone
Cytochrome P-450 CYP11B2*
Humans
Mineralocorticoid Receptor Antagonists*
Receptors, Mineralocorticoid
Spironolactone

Substances

Mineralocorticoid Receptor Antagonists
Receptors, Mineralocorticoid
Spironolactone
Aldosterone
Cytochrome P-450 CYP11B2